The Cancer Consortium

Cancer News & Information Center

Friday, October 30th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

Complete Genomics Well Positioned to Move from Research to Clinical in Genome Sequencing

By Global Cancer Consortium on April 18, 2012 • ( Leave a comment )

OneMedRadio recently conducted an interview with Dr. Clifford A. Reid, the company’s President and Chief Executive Officer.

Epigenomics Enrolls First Participant in its FIT Comparative Study with Epi proColon®

By Global Cancer Consortium on April 16, 2012 • ( Leave a comment )

OneMedRadio interviewed Thomas Taapken, CFO of Epigenomics, a Berlin based molecular diagnostics company for the early detection of cancer.

Advaxis Receives Best Therapeutic Vaccine Award

By Global Cancer Consortium on April 12, 2012 • ( Leave a comment )

The 5th Annual Vaccine Industry Excellence Awards has named Advaxis as the Best Therapeutic Vaccine for the company’s ADVX-HPV construct.

Dr. Cynthia Haines, Health Information Guru: How Patients Can Combat a Broken Healthcare System

By Global Cancer Consortium on April 6, 2012 • ( Leave a comment )

In this unprecedented age of technology and communication, many wonder why the healthcare industry has traditionally not been on the cutting edge.

Patent Infringement Special Report: Part II, History and Precedent

By Global Cancer Consortium on April 4, 2012 • ( Leave a comment )

Part two of our Special Report highlight an important case that may significantly affect the patent infringement landscape. Shares of Myriad Genetics fell 10 percent in the wake of the Mayo ruling.

This Week In Diagnostics

By Global Cancer Consortium on April 3, 2012 • ( Leave a comment )

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

OncoSec Closes $7.75 Million Public Offering

By Global Cancer Consortium on April 1, 2012 • ( Leave a comment )

OncoSec intends to use proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses.

Advaxis Nominated for Vaccine Industry Excellence Award

By Global Cancer Consortium on March 29, 2012 • ( Leave a comment )

The company has been selected for the shortlist of the 5th Annual Vaccine Industry Excellence (ViE) Awards in the category of Best Therapeutic Vaccine.

Posts navigation

‹ Newer 1 … 33 34 35 36 37 38 39 40 41 42 43 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.